ARTICLE | Clinical News
Abarelix regulatory update
October 25, 2010 7:00 AM UTC
The European Commission granted Orphan Drug designation for Speciality's abarelix to treat low-flow priapism. The luteinizing hormone-releasing hormone (LHRH)/gonadotrophin-releasing hormone (GnRH) a...